Treating polymyositis: methotrexate or azathioprine?
Mader, R.
Harefuah 132(1): 56-58
1997
ISSN/ISBN: 0017-7768 PMID: 9035572 Document Number: 477250
Document emailed within 1 workday
Related Documents
Blanche, P.; Sicard, D. 1994: Methotrexate for polymyositis associated with primary biliary cirrhosis Clinical and Experimental Rheumatology 12(6): 694Feldges, D.H.; Barnes, C.G. 1976: Treatment of psoriasis arthropathy with either azathioprine or methotrexate Schweizerische Rundschau für Medizin Praxis 65(21): 652-654
Wendt, T.; Eidner, T.; Bräunig, E.; Hein, G. 1999: Influence of methotrexate and azathioprine on radiologic progression in rheumatoid arthritis European Journal of Medical Research 4(10): 442-448
Kerstens, P.J.; Boerbooms, A.M.; Jeurissen, M.E.; de Graaf, R.; Mulder, J.; van de Putte, L.B. 2000: Radiological and clinical results of longterm treatment of rheumatoid arthritis with methotrexate and azathioprine Journal of Rheumatology 27(5): 1148-1155
Mehreen, S.; Iftikhar, S.; Muhammad, A.; Aatif Siddique, R.; Shahid, S. 2023: Efficacy of azathioprine and methotrexate in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) Pakistan Journal of Pharmaceutical Sciences 36(4(Special): 1361-1365
Saito, E.; Yoshimoto, Y.; Oshima, H.; Yoshida, H.; Kinoshita, M. 1989: Fluorescent antibodies in polymyositis using cultured human skin fibroblasts: granular perinuclear cytoplasmic staining pattern by sera from patients with polymyositis and pulmonary fibrosis Journal of Rheumatology 16(1): 47-54
Medzihradsky, J.L.; Klein, C.; Elion, G.B. 1982: Differential interference by azathioprine and 6-mercaptopurine with antibody-mediated immunoregulation: synergism of azathioprine and antibody in the control of an immune response Journal of Immunology 129(1): 145-149
Lhermitte, F.; Marteau, R.; de Saxcé, H. 1987: Treatment of progressive and severe forms of multiple sclerosis using a combination of antilymphocyte serum, azathioprine and prednisone. Clinical and biological results. Comparison with a control group treated with azathioprine and prednisone only. 4-year follow-up Revue Neurologique (Paris) 143(2): 98-107
Iqbal, M.P.; Malik, I.; Mehboobali, N. 1992: Appearance of a methotrexate binding plasma protein during high dose methotrexate therapy JPMA. Journal of the Pakistan Medical Association 42(8): 193-196
Cadman, E.C.; Glick, J.H.; Cross, J.; Horton, J.; Taylor, S.G. 1984: Sequential methotrexate and 5-FU in CMFP (cyclophosphamide, methotrexate, 5-FU, and prednisone) therapy for breast cancer Cancer Treatment Reports 68(6): 877-879
Kinahan, J.J.; Otten, M.; Grindey, G.B. 1979: Evaluation of ribonucleoside and deoxyribonucleoside triphosphate pools in cultured leukemia cells during exposure to methotrexate or methotrexate plus thymidine Cancer Research 39(9): 3531-3539
Schlegel, H.B.; Poe, M.; Hoogsteen, K. 1981: Models for the binding of methotrexate to Escherichia coli dihydrofolate reductase: direct effect of carboxylate of aspartic acid 27 upon ultraviolet spectrum of methotrexate Molecular Pharmacology 20(1): 154-158
van Dooren-Greebe, R.J.; Kuijpers, A.L.; Termorshuizen, F.; van de Kerkhof, P.C. 1995: Interruption of long-term methotrexate treatment in psoriasis. Evaluation of clinical course and laboratory parameters after discontinuation and reintroduction of weekly oral methotrexate Acta Dermato-Venereologica 75(5): 393-396
Pizzocaro, G.; Milani, A.; Piva, L.; Faustini, M.; Spino, E. 1991: Methotrexate, vinblastine, adriamycin and cisplatin versus methotrexate and cisplatin in advanced urothelial cancer. A randomized study European Urology 20(2): 89-92
Curry, S.L.; Blessing, J.A.; Disaia, P.J.; Soper, J.T.; Twiggs, L.B. 1989: A prospective randomized comparison of methotrexate, dactinomycin, and chlorambucil versus methotrexate, dactinomycin, cyclophosphamide, doxorubicin, melphalan, hydroxyurea, and vincristine in "poor prognosis" metastatic gestational trophoblastic disease: a Gynecologic Oncology Group study Obstetrics and Gynecology 73(3 Pt 1): 357-362
Scheinfeld, N. 2006: Three cases of toxic skin eruptions associated with methotrexate and a compilation of methotrexate-induced skin eruptions Dermatology Online Journal 12(7): 15
Higuchi, I. 2015: Polymyositis Nihon Rinsho. Japanese Journal of Clinical Medicine 73(Suppl 7): 561-566
Pryor, H.J. 1973: Weakness in polymyositis New England Journal of Medicine 288(21): 1128
Salmi, J.; Somer, M.R. 1978: Polymyositis and toxoplasmosis Duodecim; Laaketieteellinen Aikakauskirja 94(8): 509-513
Rozhold, O.; Vojácek, K.; Jemelík, R. 1989: Paravertebral polymyositis Acta Universitatis Palackianae Olomucensis Facultatis Medicae 121: 313-321